BLOOMIN' BRANDS INC (BLMN) Fundamental Analysis & Valuation

NASDAQ:BLMNUS0942351083

Current stock price

5.49 USD
+0.01 (+0.18%)
At close:
5.49 USD
0 (0%)
After Hours:

This BLMN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BLMN Profitability Analysis

1.1 Basic Checks

  • BLMN had positive earnings in the past year.
  • In the past year BLMN had a positive cash flow from operations.
  • Of the past 5 years BLMN 4 years were profitable.
  • In the past 5 years BLMN always reported a positive cash flow from operatings.
BLMN Yearly Net Income VS EBIT VS OCF VS FCFBLMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

1.2 Ratios

  • The Return On Assets of BLMN (0.26%) is worse than 61.90% of its industry peers.
  • BLMN has a Return On Equity (2.47%) which is in line with its industry peers.
  • BLMN has a worse Return On Invested Capital (3.81%) than 61.11% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BLMN is below the industry average of 10.68%.
Industry RankSector Rank
ROA 0.26%
ROE 2.47%
ROIC 3.81%
ROA(3y)1.23%
ROA(5y)2.66%
ROE(3y)-10.51%
ROE(5y)21.12%
ROIC(3y)6.97%
ROIC(5y)9.18%
BLMN Yearly ROA, ROE, ROICBLMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.21%, BLMN is doing worse than 61.11% of the companies in the same industry.
  • In the last couple of years the Profit Margin of BLMN has declined.
  • Looking at the Operating Margin, with a value of 2.79%, BLMN is doing worse than 73.81% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BLMN has declined.
  • BLMN has a Gross Margin of 70.24%. This is amongst the best in the industry. BLMN outperforms 85.71% of its industry peers.
  • BLMN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.79%
PM (TTM) 0.21%
GM 70.24%
OM growth 3Y-28.44%
OM growth 5YN/A
PM growth 3Y-55.15%
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y0.25%
BLMN Yearly Profit, Operating, Gross MarginsBLMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

2

2. BLMN Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BLMN is destroying value.
  • The number of shares outstanding for BLMN has been increased compared to 1 year ago.
  • BLMN has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for BLMN has been reduced compared to a year ago.
BLMN Yearly Shares OutstandingBLMN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
BLMN Yearly Total Debt VS Total AssetsBLMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • Based on the Altman-Z score of 0.83, we must say that BLMN is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of BLMN (0.83) is worse than 69.84% of its industry peers.
  • BLMN has a debt to FCF ratio of 8.25. This is a slightly negative value and a sign of low solvency as BLMN would need 8.25 years to pay back of all of its debts.
  • The Debt to FCF ratio of BLMN (8.25) is better than 63.49% of its industry peers.
  • BLMN has a Debt/Equity ratio of 2.38. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 2.38, BLMN perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.38
Debt/FCF 8.25
Altman-Z 0.83
ROIC/WACC0.51
WACC7.53%
BLMN Yearly LT Debt VS Equity VS FCFBLMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • BLMN has a Current Ratio of 0.31. This is a bad value and indicates that BLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BLMN has a worse Current ratio (0.31) than 93.65% of its industry peers.
  • A Quick Ratio of 0.24 indicates that BLMN may have some problems paying its short term obligations.
  • BLMN's Quick ratio of 0.24 is on the low side compared to the rest of the industry. BLMN is outperformed by 92.06% of its industry peers.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.24
BLMN Yearly Current Assets VS Current LiabilitesBLMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

3

3. BLMN Growth Analysis

3.1 Past

  • The earnings per share for BLMN have decreased strongly by -36.67% in the last year.
  • Measured over the past years, BLMN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -23.13% on average per year.
  • The Revenue has been growing slightly by 0.14% in the past year.
  • Measured over the past years, BLMN shows a small growth in Revenue. The Revenue has been growing by 4.53% on average per year.
EPS 1Y (TTM)-36.67%
EPS 3Y-23.13%
EPS 5YN/A
EPS Q2Q%-34.21%
Revenue 1Y (TTM)0.14%
Revenue growth 3Y-3.6%
Revenue growth 5Y4.53%
Sales Q2Q%-11.09%

3.2 Future

  • The Earnings Per Share is expected to grow by 2.40% on average over the next years.
  • Based on estimates for the next years, BLMN will show a small growth in Revenue. The Revenue will grow by 1.59% on average per year.
EPS Next Y-23.76%
EPS Next 2Y-6.36%
EPS Next 3Y2.4%
EPS Next 5YN/A
Revenue Next Year0.02%
Revenue Next 2Y0.92%
Revenue Next 3Y1.59%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BLMN Yearly Revenue VS EstimatesBLMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
BLMN Yearly EPS VS EstimatesBLMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2

7

4. BLMN Valuation Analysis

4.1 Price/Earnings Ratio

  • BLMN is valuated cheaply with a Price/Earnings ratio of 4.82.
  • Based on the Price/Earnings ratio, BLMN is valued cheaply inside the industry as 97.62% of the companies are valued more expensively.
  • BLMN is valuated cheaply when we compare the Price/Earnings ratio to 25.60, which is the current average of the S&P500 Index.
  • BLMN is valuated cheaply with a Price/Forward Earnings ratio of 6.32.
  • Based on the Price/Forward Earnings ratio, BLMN is valued cheaply inside the industry as 96.83% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 22.84. BLMN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.82
Fwd PE 6.32
BLMN Price Earnings VS Forward Price EarningsBLMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BLMN indicates a rather cheap valuation: BLMN is cheaper than 92.86% of the companies listed in the same industry.
  • BLMN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BLMN is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.84
EV/EBITDA 4.19
BLMN Per share dataBLMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.36%
EPS Next 3Y2.4%

6

5. BLMN Dividend Analysis

5.1 Amount

  • BLMN has a Yearly Dividend Yield of 5.70%, which is a nice return.
  • Compared to an average industry Dividend Yield of 1.11, BLMN pays a better dividend. On top of this BLMN pays more dividend than 97.62% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.88, BLMN pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.7%

5.2 History

  • The dividend of BLMN is nicely growing with an annual growth rate of 17.58%!
  • BLMN has paid a dividend for at least 10 years, which is a reliable track record.
  • BLMN has decreased its dividend in the last 3 years.
Dividend Growth(5Y)17.58%
Div Incr Years0
Div Non Decr Years2
BLMN Yearly Dividends per shareBLMN Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • BLMN pays out 464.56% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of BLMN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP464.56%
EPS Next 2Y-6.36%
EPS Next 3Y2.4%
BLMN Yearly Income VS Free CF VS DividendBLMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M
BLMN Dividend Payout.BLMN Dividend Payout, showing the Payout Ratio.BLMN Dividend Payout.PayoutRetained Earnings

BLMN Fundamentals: All Metrics, Ratios and Statistics

BLOOMIN' BRANDS INC

NASDAQ:BLMN (4/2/2026, 8:10:04 PM)

After market: 5.49 0 (0%)

5.49

+0.01 (+0.18%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-25
Earnings (Next)04-24
Inst Owners102.18%
Inst Owner Change-0.94%
Ins Owners1.73%
Ins Owner Change10.27%
Market Cap467.97M
Revenue(TTM)3.96B
Net Income(TTM)8.24M
Analysts69
Price Target7.61 (38.62%)
Short Float %10.57%
Short Ratio2.92
Dividend
Industry RankSector Rank
Dividend Yield 5.7%
Yearly Dividend0.45
Dividend Growth(5Y)17.58%
DP464.56%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)37.66%
Min EPS beat(2)-0.37%
Max EPS beat(2)75.69%
EPS beat(4)3
Avg EPS beat(4)23.2%
Min EPS beat(4)-0.37%
Max EPS beat(4)75.69%
EPS beat(8)5
Avg EPS beat(8)9.37%
EPS beat(12)9
Avg EPS beat(12)8.91%
EPS beat(16)13
Avg EPS beat(16)7.95%
Revenue beat(2)1
Avg Revenue beat(2)-1.08%
Min Revenue beat(2)-2.58%
Max Revenue beat(2)0.41%
Revenue beat(4)1
Avg Revenue beat(4)-0.64%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.28%
Revenue beat(12)2
Avg Revenue beat(12)-1.39%
Revenue beat(16)3
Avg Revenue beat(16)-1.47%
PT rev (1m)-0.28%
PT rev (3m)-2.8%
EPS NQ rev (1m)1.57%
EPS NQ rev (3m)-3.84%
EPS NY rev (1m)-1.41%
EPS NY rev (3m)-6.75%
Revenue NQ rev (1m)-1.3%
Revenue NQ rev (3m)-1.48%
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)-0.3%
Valuation
Industry RankSector Rank
PE 4.82
Fwd PE 6.32
P/S 0.12
P/FCF 4.84
P/OCF 1.69
P/B 1.4
P/tB N/A
EV/EBITDA 4.19
EPS(TTM)1.14
EY20.77%
EPS(NY)0.87
Fwd EY15.83%
FCF(TTM)1.14
FCFY20.68%
OCF(TTM)3.25
OCFY59.13%
SpS46.41
BVpS3.91
TBVpS-3.51
PEG (NY)N/A
PEG (5Y)N/A
Graham Number10.02
Profitability
Industry RankSector Rank
ROA 0.26%
ROE 2.47%
ROCE 4.82%
ROIC 3.81%
ROICexc 3.91%
ROICexgc 5.45%
OM 2.79%
PM (TTM) 0.21%
GM 70.24%
FCFM 2.45%
ROA(3y)1.23%
ROA(5y)2.66%
ROE(3y)-10.51%
ROE(5y)21.12%
ROIC(3y)6.97%
ROIC(5y)9.18%
ROICexc(3y)7.23%
ROICexc(5y)9.53%
ROICexgc(3y)10.36%
ROICexgc(5y)14%
ROCE(3y)8.82%
ROCE(5y)11.62%
ROICexgc growth 3Y-32.33%
ROICexgc growth 5YN/A
ROICexc growth 3Y-30.79%
ROICexc growth 5YN/A
OM growth 3Y-28.44%
OM growth 5YN/A
PM growth 3Y-55.15%
PM growth 5YN/A
GM growth 3Y0.76%
GM growth 5Y0.25%
F-Score7
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 2.38
Debt/FCF 8.25
Debt/EBITDA 2.76
Cap/Depr 101.26%
Cap/Sales 4.55%
Interest Coverage 1.89
Cash Conversion 96.02%
Profit Quality 1174.82%
Current Ratio 0.31
Quick Ratio 0.24
Altman-Z 0.83
F-Score7
WACC7.53%
ROIC/WACC0.51
Cap/Depr(3y)132.2%
Cap/Depr(5y)120.26%
Cap/Sales(3y)5.97%
Cap/Sales(5y)5.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.67%
EPS 3Y-23.13%
EPS 5YN/A
EPS Q2Q%-34.21%
EPS Next Y-23.76%
EPS Next 2Y-6.36%
EPS Next 3Y2.4%
EPS Next 5YN/A
Revenue 1Y (TTM)0.14%
Revenue growth 3Y-3.6%
Revenue growth 5Y4.53%
Sales Q2Q%-11.09%
Revenue Next Year0.02%
Revenue Next 2Y0.92%
Revenue Next 3Y1.59%
Revenue Next 5YN/A
EBIT growth 1Y-46.08%
EBIT growth 3Y-31.02%
EBIT growth 5YN/A
EBIT Next Year109.31%
EBIT Next 3Y33.67%
EBIT Next 5YN/A
FCF growth 1Y1208.59%
FCF growth 3Y-17.32%
FCF growth 5Y13.67%
OCF growth 1Y21.29%
OCF growth 3Y-10.88%
OCF growth 5Y14.79%

BLOOMIN' BRANDS INC / BLMN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BLOOMIN' BRANDS INC (BLMN) stock?

ChartMill assigns a fundamental rating of 4 / 10 to BLMN.


Can you provide the valuation status for BLOOMIN' BRANDS INC?

ChartMill assigns a valuation rating of 7 / 10 to BLOOMIN' BRANDS INC (BLMN). This can be considered as Undervalued.


Can you provide the profitability details for BLOOMIN' BRANDS INC?

BLOOMIN' BRANDS INC (BLMN) has a profitability rating of 3 / 10.


What is the valuation of BLOOMIN' BRANDS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BLOOMIN' BRANDS INC (BLMN) is 4.82 and the Price/Book (PB) ratio is 1.4.


What is the financial health of BLOOMIN' BRANDS INC (BLMN) stock?

The financial health rating of BLOOMIN' BRANDS INC (BLMN) is 2 / 10.